Targeted inhibition of gut microbiota proteins involved in TMAO production to reduce platelet aggregation and arterial thrombosis: a blueprint for drugging the microbiota in the treatment of cardiometabolic disease?

van Mens T. E.; Buller H. R.; Nieuwdorp M.

首页> 外文期刊>Journal of thrombosis and haemostasis: JTH >Targeted inhibition of gut microbiota proteins involved in TMAO production to reduce platelet aggregation and arterial thrombosis: a blueprint for drugging the microbiota in the treatment of cardiometabolic disease?

【24h】

Targeted inhibition of gut microbiota proteins involved in TMAO production to reduce platelet aggregation and arterial thrombosis: a blueprint for drugging the microbiota in the treatment of cardiometabolic disease?

机译：针对肠道微生物蛋白的靶向抑制，参与TMAO生产以减少血小板聚集和动脉血栓形成：用于在治疗心细素疾病的微生物群中吸毒的蓝图？

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of thrombosis and haemostasis: JTH》 |2019年第1期|共3页
作者
van Mens T. E.; Buller H. R.; Nieuwdorp M.;
展开▼
作者单位

Univ Amsterdam Dept Vasc Med Amsterdam Cardiovasc Sci Amsterdam UMC Meibergdreef 9 Amsterdam;

Univ Amsterdam Dept Vasc Med Amsterdam Cardiovasc Sci Amsterdam UMC Meibergdreef 9 Amsterdam;

Univ Amsterdam Dept Vasc Med Amsterdam Cardiovasc Sci Amsterdam UMC Meibergdreef 9 Amsterdam;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类临床医学;
关键词

相似文献

外文文献
中文文献
专利

1. Targeted inhibition of gut microbiota proteins involved in TMAO production to reduce platelet aggregation and arterial thrombosis: a blueprint for drugging the microbiota in the treatment of cardiometabolic disease? [J] . van Mens T. E., Buller H. R., Nieuwdorp M. Journal of thrombosis and haemostasis: JTH . 2019,第1期

机译：针对肠道微生物蛋白的靶向抑制，参与TMAO生产以减少血小板聚集和动脉血栓形成：用于在治疗心细素疾病的微生物群中吸毒的蓝图？
2. Balancing Herbal Medicine and Functional Food for Prevention and Treatment of Cardiometabolic Diseases through Modulating Gut Microbiota [J] . Ming Lyu, Yue-fei Wang, Guan-wei Fan, Frontiers in Microbiology . 2017,第6期

机译：通过调节肠道菌群来平衡草药和功能性食品，以预防和治疗心脏代谢疾病
3. Gut microbiota and probiotics intervention: A potential therapeutic target for management of cardiometabolic disorders and chronic kidney disease? [J] . Cavalcanti Neto Marinaldo Pacifico, Aquino Jailane de Souza, Romao da Silva Larissa de Fatima, Pharmacological research: The official journal of The Italian Pharmacological Society . 2018,第期

机译：Gut microbiota和益生菌干预：心细镜障碍和慢性肾病的管理潜在治疗目标？
4. Gut Microbiota-Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism Clinical Prognostic and Potential as a Therapeutic Target [O] . Shengjie Yang, Xinye Li, Fan Yang, 2019

机译：肠道微生物群依赖性标记TMAO促进心血管疾病：炎症机制临床预后以及作为治疗目标的潜力
5. Targeted inhibition of gut microbiota proteins involved in TMAO production to reduce platelet aggregation and arterial thrombosis: a blueprint for drugging the microbiota in the treatment of cardiometabolic disease? [O] . T. E. Mens, H. R. Büller, M. Nieuwdorp 2018

机译：针对肠道微生物蛋白的靶向抑制参与TMAO生产以减少血小板聚集和动脉血栓形成：用于在治疗心细素疾病的微生物群中吸毒的蓝图？

Targeted inhibition of gut microbiota proteins involved in TMAO production to reduce platelet aggregation and arterial thrombosis: a blueprint for drugging the microbiota in the treatment of cardiometabolic disease?

著录项

相似文献

相关主题

期刊订阅